Methods, compositions, and automated systems for separating rare cells from fluid samples
CA 2462914 A1 · Owner: Aviva Biosciences Corporation · Inventors: Xu, Junquan; Hujsak, Paul; Yang, Zhaohuai
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The present invention recognizes that diagnosis and prognosis of many conditions can depend on the enrichment of rare cells from a complex fluid sample. In particular, the enrichment of fetal cells from maternal samples such as maternal blood samples, can greatly aid in the detection of fetal abnormalities or a variety of genetic conditions. In addition the present , invention recognizes that the enrichment of rare malignant cells from patient samples, can aid in diagnosis, prognosis and development of therapeutic , modalities for patients.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed October 10, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended October 10, 2022.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by October 10, 2024.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.